Eugène McFadden

28.7k total citations · 6 hit papers
143 papers, 16.5k citations indexed

About

Eugène McFadden is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eugène McFadden has authored 143 papers receiving a total of 16.5k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Surgery, 96 papers in Cardiology and Cardiovascular Medicine and 69 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eugène McFadden's work include Coronary Interventions and Diagnostics (101 papers), Cardiac Imaging and Diagnostics (66 papers) and Acute Myocardial Infarction Research (39 papers). Eugène McFadden is often cited by papers focused on Coronary Interventions and Diagnostics (101 papers), Cardiac Imaging and Diagnostics (66 papers) and Acute Myocardial Infarction Research (39 papers). Eugène McFadden collaborates with scholars based in Netherlands, France and United States. Eugène McFadden's co-authors include Patrick W. Serruys, Pim J. de Feyter, Pascal Vranckx, Donald E. Cutlip, Martial Hamon, Stephan Windecker, Gerrit‐Anne van Es, Roxana Mehran, Mitchell W. Krucoff and Marie‐Angèle Morel and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Eugène McFadden

140 papers receiving 15.9k citations

Hit Papers

Clinical End Points in Coronary Stent Trials 2004 2026 2011 2018 2007 2004 2005 2005 2018 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical End Points in Coronary Stent Trials
    2007 4.2k citations Donald E. Cutlip, Stephan Windecker et al. Circulation profile →
  2. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
    2004 1.0k citations Eugène McFadden, Evelyn Regar et al. profile →
  3. High-Resolution Spiral Computed Tomography Coronary Angiography in Patients Referred for Diagnostic Conventional Coronary Angiography
    2005 801 citations Nico R. Mollet, Filippo Cademartiri et al. Circulation profile →
  4. Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting Stents
    2005 528 citations Andrew T.L. Ong, Eugène McFadden et al. Journal of the American College of Cardiology profile →
  5. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
    2018 514 citations Héctor M. García‐García, Eugène McFadden et al. Circulation profile →
  6. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
    2010 475 citations Elvin Kedhi, Kaiyum Sheik Joesoef et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugène McFadden Netherlands 53 12.4k 11.3k 6.7k 3.0k 1.5k 143 16.5k
Peter J. Fitzgerald United States 61 12.7k 1.0× 8.8k 0.8× 6.8k 1.0× 4.7k 1.6× 1.2k 0.8× 351 15.5k
Seung‐Jung Park South Korea 64 13.1k 1.1× 10.8k 1.0× 8.8k 1.3× 3.7k 1.3× 1.4k 0.9× 505 17.0k
Myeong‐Ki Hong South Korea 57 11.7k 0.9× 10.1k 0.9× 5.7k 0.9× 3.5k 1.2× 642 0.4× 615 15.2k
Giulio Guagliumi Italy 65 14.3k 1.2× 13.6k 1.2× 6.8k 1.0× 4.7k 1.6× 1.4k 1.0× 263 20.1k
Guy R. Heyndrickx Belgium 56 9.5k 0.8× 9.3k 0.8× 7.8k 1.2× 2.1k 0.7× 912 0.6× 169 14.3k
Cheol Whan Lee South Korea 58 10.1k 0.8× 8.4k 0.7× 6.3k 0.9× 2.8k 0.9× 579 0.4× 389 12.6k
Robert A. Byrne Germany 60 9.3k 0.7× 8.3k 0.7× 3.2k 0.5× 3.2k 1.1× 1.1k 0.7× 332 12.9k
Marco A. Costa United States 51 7.9k 0.6× 6.4k 0.6× 3.1k 0.5× 2.7k 0.9× 1.4k 1.0× 230 11.8k
Paul S. Teirstein United States 52 10.0k 0.8× 7.8k 0.7× 4.4k 0.7× 3.4k 1.1× 417 0.3× 182 12.5k
Akiko Maehara United States 61 13.2k 1.1× 8.7k 0.8× 9.9k 1.5× 5.2k 1.8× 1.4k 1.0× 501 16.5k

Countries citing papers authored by Eugène McFadden

Since Specialization
Citations

This map shows the geographic impact of Eugène McFadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugène McFadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugène McFadden more than expected).

Fields of papers citing papers by Eugène McFadden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugène McFadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugène McFadden. The network helps show where Eugène McFadden may publish in the future.

Co-authorship network of co-authors of Eugène McFadden

This figure shows the co-authorship network connecting the top 25 collaborators of Eugène McFadden. A scholar is included among the top collaborators of Eugène McFadden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugène McFadden. Eugène McFadden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valdés‐Chávarri, Mariano, Saško Kedev, Aleksandar Nešković, et al.. (2019). Randomised evaluation of a novel biodegradable polymer-based sirolimus-eluting stent in ST-segment elevation myocardial infarction: the MASTER study. EuroIntervention. 14(18). e1836–e1842. 10 indexed citations
2.
Spitzer, Ernest, Eugène McFadden, Pascal Vranckx, et al.. (2019). Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials. JACC: Cardiovascular Interventions. 12(9). 805–819. 17 indexed citations
3.
García‐García, Héctor M., Eugène McFadden, Clemens von Birgelen, et al.. (2019). Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions. 12(19). 1954–1962. 42 indexed citations
4.
Spitzer, Ernest, Eugène McFadden, Pascal Vranckx, et al.. (2018). Defining Staged Procedures for Percutaneous Coronary Intervention Trials. JACC: Cardiovascular Interventions. 11(9). 823–832. 11 indexed citations
5.
Arampatzis, Chourmouzios A., Danai Chourmouzi, Pedro A. Lemos, et al.. (2016). Graft failure prior to discharge after coronary artery bypass surgery: a prospective single-centre study using dual 64-slice computed tomography. EuroIntervention. 12(8). e972–e978. 9 indexed citations
6.
Smits, Pieter C., Kees‐Jan Royaards, Georgios J. Vlachojannis, et al.. (2013). TCT-13 Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents. Journal of the American College of Cardiology. 62(18). B5–B5. 2 indexed citations
7.
8.
Smits, Pieter C., Elvin Kedhi, Kees‐Jan Royaards, et al.. (2011). 2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice. Journal of the American College of Cardiology. 58(1). 11–18. 153 indexed citations
9.
Mollet, Nico R., Filippo Cademartiri, Carlos A.G. van Mieghem, et al.. (2005). High-Resolution Spiral Computed Tomography Coronary Angiography in Patients Referred for Diagnostic Conventional Coronary Angiography. Circulation. 112(15). 2318–2323. 801 indexed citations breakdown →
10.
Lemos, Pedro A., Chourmouzios A. Arampatzis, Angela Hoye, et al.. (2005). Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. The American Journal of Cardiology. 95(2). 167–172. 81 indexed citations
11.
Aoki, Jiro, Patrick W. Serruys, Heleen van Beusekom, et al.. (2005). Endothelial Progenitor Cell Capture by Stents Coated With Antibody Against CD34. Journal of the American College of Cardiology. 45(10). 1574–1579. 425 indexed citations
12.
Lemos, Pedro A., Francesco Saia, Sjoerd H. Hofma, et al.. (2004). Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. Journal of the American College of Cardiology. 43(4). 704–708. 135 indexed citations
13.
Groote, Pascal de, J. Dagorn, Benoı̂t Soudan, et al.. (2004). B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. Journal of the American College of Cardiology. 43(9). 1584–1589. 103 indexed citations
14.
Arampatzis, Chourmouzios A., Angela Hoye, Pedro A. Lemos, et al.. (2004). Elective sirolimus‐eluting stent implantation for multivessel disease involving significant LAD stenosis: One‐year clinical outcomes of 99 consecutive patients—the Rotterdam experience. Catheterization and Cardiovascular Interventions. 63(1). 57–60. 14 indexed citations
15.
Lemos, Pedro A., Chourmouzios A. Arampatzis, Francesco Saia, et al.. (2004). Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry). The American Journal of Cardiology. 93(5). 633–636. 39 indexed citations
16.
Bauters, Christophe, Edouard Hubert, Alain Prat, et al.. (1998). Predictors of Restenosis After Coronary Stent Implantation. Journal of the American College of Cardiology. 31(6). 1291–1298. 218 indexed citations
17.
Bertrand, Michel E., Eugène McFadden, Jean‐Charles Fruchart, et al.. (1997). Effect of Pravastatin on Angiographic Restenosis After Coronary Balloon Angioplasty fn1fn1This study was supported by a grant from Bristol Myers Squibb Laboratories, Paris.. Journal of the American College of Cardiology. 30(4). 863–869. 109 indexed citations
18.
Bauters, Christophe, Jean‐Marc Lablanche, Eugène McFadden, Fabrice Leroy, & Michel E. Bertrand. (1992). Clinical characteristics and angiographie follow-up of patients undergoing early or late repeat dilation for a first restenosis. Journal of the American College of Cardiology. 20(4). 845–848. 38 indexed citations
19.
Gavrielides, Stavros, et al.. (1991). Comparison of epicardial coronary artery tone and reactivity in Prinzmetal's variant angina and chronic stable angina pectoris. Journal of the American College of Cardiology. 17(5). 1058–1062. 31 indexed citations
20.
Tousoulis, Dimitris, et al.. (1991). Epicardial coronary artery tone and reactivity in patients with normal coronary arteriograms and reduced coronary flow reserve (syndrome X). Journal of the American College of Cardiology. 18(1). 50–54. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter J. Fitzgerald Breakdown of academic impact, for papers by Seung‐Jung Park Breakdown of academic impact, for papers by Myeong‐Ki Hong Breakdown of academic impact, for papers by Giulio Guagliumi Breakdown of academic impact, for papers by Guy R. Heyndrickx Breakdown of academic impact, for papers by Cheol Whan Lee Breakdown of academic impact, for papers by Robert A. Byrne Breakdown of academic impact, for papers by Marco A. Costa Breakdown of academic impact, for papers by Paul S. Teirstein Breakdown of academic impact, for papers by Akiko Maehara
Rankless by CCL
2026